Atlas Trials

MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

Clinical trial NCT03675139 · COMPLETED

Trial details

NCT number
NCT03675139
Sponsor
Xiaojun Chen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Endometrial Hyperplasia Without Atypia
Start date
2019-02-26
Primary completion
2022-05-14
Enrollment
471

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.